Zobrazeno 1 - 10
of 139
pro vyhledávání: '"JC Biggs"'
Autor:
JC Biggs, J Szer, P Crilley, K Atkinson, K Downs, A Dodds, AJ Concannon, B Avalos, P Tutschka, N Kapoor
Publikováno v:
Blood. 80:1352-1357
One hundred fifteen patients with chronic myelocytic leukemia (CML) were administered busulphan 4 mg/kg for 4 days and cyclophosphamide 60 mg/kg on each of 2 days (BuCy2) followed by allogeneic bone marrow transplantation from histocompatible sibling
Autor:
EA Copelan, JC Biggs, JM Thompson, P Crilley, J Szer, JP Klein, N Kapoor, BR Avalos, I Cunningham, K Atkinson
Publikováno v:
Blood. 78:838-843
One hundred twenty-seven patients with acute myelocytic leukemia (AML) were given busulfan 4 mg/kg on each of 4 days and cyclophosphamide 60 mg/kg on each of 2 days (BuCy2) followed by allogeneic bone marrow transplantation from an HLA-identical or o
Autor:
Js, Wiley, Jonathan Cebon, Gp, Jamieson, Szer J, Gibson J, Rk, Woodruff, Jj, Mckendrick, Wp, Sheridan, Jc, Biggs, Mb, Snook
Publikováno v:
Europe PubMed Central
Nucleoside transporter expression has been linked to proliferation in a variety of haemopoietic cell types. Granulocyte-macrophage colony-stimulating factor (GM-CSF) was given for 72 h before commencing chemotherapy in 15 patients with relapsed or re
Autor:
Js, Wiley, Gp, Jamieson, Jonathan Cebon, Rk, Woodruff, Jj, Mckendrick, Szer J, Gibson J, Wp, Sheridan, Jc, Biggs, Mc, Rallings
Publikováno v:
Europe PubMed Central
Autor:
JC Biggs, MM Horowitz, RP Gale, RC Ash, K Atkinson, W Helbig, N Jacobsen, GL Phillips, AA Rimm, O Ringden
Publikováno v:
Blood. 80(4)
About 30% of adults with acute lymphoblastic leukemia (ALL) and 20% to 40% of children and adults with acute myelogenous leukemia (AML) never achieve remission, even with intensive chemotherapy. Most die of resistant leukemia, often within 6 months o
Autor:
E Gluckman, MM Horowitz, RE Champlin, JM Hows, A Bacigalupo, JC Biggs, BM Camitta, RP Gale, EC Gordon-Smith, AM Marmont
Publikováno v:
Blood. 79(1)
Data for 595 patients with severe aplastic anemia receiving HLA- identical sibling bone marrow transplants were analyzed to determine the effect of pretransplant conditioning and graft-versus-host disease (GVHD) prophylaxis on outcome. Transplants we
Publikováno v:
Communications in agricultural and applied biological sciences [Commun Agric Appl Biol Sci] 2013; Vol. 78 (4), pp. 81-4.
Publikováno v:
Leukemia research [Leuk Res] 2001 Apr; Vol. 25 (4), pp. 359-60.
Autor:
Giralt S; International Bone Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Szydlo R, Goldman JM, Veum-Stone J, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM
Publikováno v:
Blood [Blood] 2000 Jan 15; Vol. 95 (2), pp. 410-5.